Infectious Disease Research Institute Email Format
BiotechnologyWashington, United States51-200 Employees
IDRI is a nonprofit biotechnology organization focused on advancing solutions for infectious diseases. It merges rigorous scientific research with product development capabilities, supported by an on-site GMP manufacturing facility. Based in Seattle, Washington, the organization operates with a mid-sized staff and collaborates with other research institutions and biotech partners to move candidates toward practical use. In December 2021, IDRI participated in a consortium to develop a next-generation COVID-19 vaccine designed to be stable at routine temperatures and potentially confer longer-lasting immunity. The organization builds partnerships with universities, biotech firms, and contract development organizations to accelerate vaccine candidates and related platforms. Through this model, IDRI serves as a link between academic research and product development within the biotechnology field, leveraging its development capabilities to advance infectious-disease solutions.